| 2022-09-08 |
Photys Therapeutics |
Mass General Brigham Ventures investment in Series A - Photys Therapeutics |
75 M USD |
| 2022-05-18 |
SwanBio Therapeutics |
Mass General Brigham Ventures investment in Series B - SwanBio Therapeutics |
56 M USD |
| 2022-01-13 |
DexCare |
Mass General Brigham Ventures investment in Series B - DexCare |
50 M USD |
| 2021-09-23 |
Garuda Therapeutics |
Mass General Brigham Ventures investment in Series A - Garuda Therapeutics |
72 M USD |
| 2021-09-16 |
Amolyt Pharma |
Mass General Brigham Ventures investment in Series B - Amolyt Pharma |
80 M USD |
| 2021-09-14 |
ROME Therapeutics |
Mass General Brigham Ventures investment in Series B - ROME Therapeutics |
77 M USD |
| 2021-06-24 |
Lyndra Therapeutics |
Mass General Brigham Ventures investment in Series C - Lyndra Therapeutics |
60.5 M USD |
| 2021-05-03 |
Affinia Therapeutics |
Mass General Brigham Ventures investment in Series B - Affinia Therapeutics |
110 M USD |
| 2021-04-07 |
Carta Healthcare |
Mass General Brigham Ventures investment in Series A - Carta Healthcare |
17.3 M USD |
| 2021-04-02 |
SeQure DX |
Mass General Brigham Ventures investment in Series A - SeQure DX |
17.5 M USD |